文献速递妇科

晚期卵巢癌直肠乙状结肠肌层浆膜受累:盆腔腹膜切除联合直肠乙状结肠切除与单纯盆腔腹膜切除的比较

Rectosigmoidectomy versus pelvic peritonectomy in the management of seromuscular involvement of superficial rectal wall tumors in advanced-stage ovarian cancer at complete interval cytoreductive surgery.
PubMed 文献 · Gynecol Oncol · 2026-02-25

该回顾性研究纳入2008至2024年西班牙一家医院161例FIGO III-IV期卵巢癌患者,比较盆腔腹膜切除(PP)与PP联合直肠乙状结肠切除(PP+RSR)在完全间歇性肿瘤细胞减灭术加HIPEC中的效果。倾向评分匹配后每组35例,两组盆腔复发率、无病生存和总生存无显著差异,但PP+RSR组住院时间更长、严重并发症和再手术率更高。

要点

  • PP+RSR与PP在盆腔复发率、无病生存和总生存上无显著差异。
  • PP+RSR组住院时间更长(中位11天 vs 7天)。
  • PP+RSR组严重并发症(28.6% vs 5.8%)和再手术率更高。

核心结论

  • 在该队列中,经多变量和倾向评分加权调整后,两种手术方式的无病生存和总生存无统计学显著差异。
  • 盆腔腹膜切除与较低的手术并发症相关。

研究设计与样本

  • 患者接受PP或PP+RSR,采用倾向评分匹配减少选择偏倚,匹配后每组35例进行分析。

主要发现

  • 盆腔复发率:PP组86% vs PP+RSR组68.6%,p=0.075,无显著差异。
  • 无病生存:HR=1.03,95%CI 0.55-1.90,p=0.94。
  • 总生存:HR=1.07,95%CI 0.59-1.94,p=0.816。
  • 住院时间:PP+RSR组中位11天(IQR 8-13) vs PP组7天(IQR 6-8),p<0.001。
  • 严重并发症:PP+RSR组28.6% vs PP组5.8%,p=0.004;再手术:PP+RSR组5例(14.7%) vs PP组1例(1.5%),p=0.035。

临床怎么用

  • 对于晚期卵巢癌直肠乙状结肠肌层浆膜受累患者,PP+RSR并未显著改善盆腔复发或生存,且增加住院时间和严重并发症。
  • 在完全间歇性肿瘤细胞减灭术加HIPEC中,选择PP而非PP+RSR可能降低手术并发症。

局限性

  • 样本量有限,置信区间较宽, findings应谨慎解读。
  • 回顾性研究设计可能存在选择偏倚,尽管使用了倾向评分匹配。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the efficacy of pelvic peritonectomy (PP) versus pelvic peritonectomy with rectosigmoid resection (PP + RSR) in managing advanced ovarian cancer (AOC) with seromuscular involvement of the rectosigmoid colon during complete interval cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC). METHODS: This retrospective study included 161 patients with FIGO stage III-IV ovarian cancer who underwent either PP or PP + RSR at Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain, from January 2008 to December 2024. Propensity score matching was utilized to minimize selection biases. Surgical outcomes, including pelvic recurrence rates, disease-free survival (DFS), overall survival (OS), and postoperative complications, were analyzed. RESULTS: After propensity score matching, 35 patients were analyzed for each group (PP + RSR and PP). No significant differences were observed in pelvic recurrence rates, despite increased recurrences in the pelvic peritonectomy group (86% vs. 68.6%, p = 0.075), nor in survival outcomes (Disease-free survival; Hazard Ratio (HR) = 1.03, 95% confidence interval (CI) 0.55-1.90, p = 0.94 and overall survival HR = 1.07, 95% CI 0.59-1.94, p = 0.816). However, the PP + RSR group experienced longer hospital stays (median 7 days [IQR 6-8] vs.11 days [IQR 8-13], p < 0.001) and higher rates of severe complications (28.6% vs. 5.8%, p = 0.004) and re-operations (1 (1.5%) vs. 5 (14.7%), p = 0.035). CONCLUSIONS: In this cohort, no statistically significant differences were observed in disease-free survival and overall survival between the surgical approaches after multivariable and propensity score-weighted adjustment. However, due to the limited sample size and wide confidence intervals, these findings should be interpreted with caution. Furthermore, pelvic peritonectomy was associated with reduced surgical morbidity.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Guijarro-Campillo AR, González-Gil A, Gil-Gómez E, et al. Rectosigmoidectomy versus pelvic peritonectomy in the management of seromuscular involvement of superficial rectal wall tumors in advanced-stage ovarian cancer at complete interval cytoreductive surgery. Gynecol Oncol. 2026. PMID: 41747472. doi:10.1016/j.ygyno.2026.02.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。